TY - JOUR
T1 - Survival and clinical features in Hispanic amyotrophic lateral sclerosis patients
AU - Martínez, Héctor R.
AU - Molina-López, Juan Francisco
AU - Cantú-Martínez, Leonel
AU - González-Garza, María Teresa
AU - Moreno-Cuevas, Jorge E.
AU - Couret-Alcaraz, Patricio
AU - Treviño, Sergio A.
AU - Webb-Vargas, Yenny
AU - Caro, Enrique
AU - Gil-Valadez, Alfonso
AU - Santos-Guzmán, Jesús
AU - Hernandez-Torre, Martin
PY - 2011/5/1
Y1 - 2011/5/1
N2 - The demography, survival, and motor phenotypes of amyotrophic lateral sclerosis (ALS) patients have been rarely described in Hispanic countries. The clinical characteristics and survival of a series of Mexican ALS patients are described. Mexican patients with definite ALS were included in a five-year retrospective longitudinal study. Their demographic and clinical features, cumulative survival rates, and independent predictive factors for survival were analysed. Sixty-one definite ALS patients were included. The median follow-up period was 35 months (range 12-108 months). Males were predominant (1.8: 1), the mean age at onset was 47.5 ± 10.5 years, and the median interval from onset to diagnosis was 12 months. Spinal onset occurred in 66% of patients. Upper motor neuron phenotype was predominant in 53% of patients. The overall mean survival from onset was 68.6 months, and from diagnosis was 57.8 months. Longer survival was determined in patients aged ≤ 40 years (54.7 months) compared with other age groups (p = 0.006). In conclusion, the clinical heterogeneity, male predominance, and survival rates in our sample are consistent with those of other studies. Patients in this series had a younger age at onset and a clear trend toward longer survival compared with those of other population studies.
AB - The demography, survival, and motor phenotypes of amyotrophic lateral sclerosis (ALS) patients have been rarely described in Hispanic countries. The clinical characteristics and survival of a series of Mexican ALS patients are described. Mexican patients with definite ALS were included in a five-year retrospective longitudinal study. Their demographic and clinical features, cumulative survival rates, and independent predictive factors for survival were analysed. Sixty-one definite ALS patients were included. The median follow-up period was 35 months (range 12-108 months). Males were predominant (1.8: 1), the mean age at onset was 47.5 ± 10.5 years, and the median interval from onset to diagnosis was 12 months. Spinal onset occurred in 66% of patients. Upper motor neuron phenotype was predominant in 53% of patients. The overall mean survival from onset was 68.6 months, and from diagnosis was 57.8 months. Longer survival was determined in patients aged ≤ 40 years (54.7 months) compared with other age groups (p = 0.006). In conclusion, the clinical heterogeneity, male predominance, and survival rates in our sample are consistent with those of other studies. Patients in this series had a younger age at onset and a clear trend toward longer survival compared with those of other population studies.
UR - http://www.scopus.com/inward/record.url?scp=79955759596&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79955759596&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/a32bf194-b422-3f97-b645-27c8a5c13cc8/
U2 - 10.3109/17482968.2010.550302
DO - 10.3109/17482968.2010.550302
M3 - Article
C2 - 21344998
AN - SCOPUS:79955759596
SN - 1748-2968
VL - 12
SP - 199
EP - 205
JO - Amyotrophic Lateral Sclerosis
JF - Amyotrophic Lateral Sclerosis
IS - 3
ER -